INMED PHARMACEUTICALS INC. Number of Reportable Segments
INMED PHARMACEUTICALS INC. (INM) reported Number of Reportable Segments of 1 Segments for the 12-month period ending 2026-06-30, per its S-4/A filed 2026-09-09.
Financial Statements › Notes › Segment Reporting
us-gaap:NumberOfReportableSegments · last filed 2026-09-09
Segments
| Period end | Number of Reportable Segments 9 month | Number of Reportable Segments 12 month |
|---|---|---|
| 2026-06-30 | 1.00 Segments S-4/A · filed 2026-09-09 | |
| 2026-03-31 | 1.00 Segments 10-Q · filed 2026-05-06 |
SEGMENTS
| Period end | Number of Reportable Segments 9 month |
|---|---|
| 2026-03-31 | 1.00 SEGMENTS S-4 · filed 2026-07-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Apimeds Pharmaceuticals US, Inc. (APUS) | United States | $0.008B | |
| Ensysce Biosciences, Inc. (ENSC) | United States | $0.008B | -0.37 |
| CNS Pharmaceuticals, Inc. (CNSP) | United States | $0.007B | |
| EXICURE, INC. (XCUR) | United States | $0.008B | -1.54 |
| Acurx Pharmaceuticals, Inc. (ACXP) | United States | $0.007B | -0.97 |
| SOLIGENIX, INC. (SNGX) | United States | $0.008B | |
| Imunon, Inc. (IMNN) | United States | $0.008B | -0.56 |
| SYNLOGIC, INC. (SYBX) | United States | $0.007B | |
| Bolt Biotherapeutics, Inc. (BOLT) | United States | $0.007B | -0.26 |
| Enveric Biosciences, Inc. (ENVB) | United States | $0.007B | -0.63 |